Side-by-side comparison of AI visibility scores, market position, and capabilities
Virtual addiction treatment platform for alcohol and opioid use disorder, Ann Arbor MI, raised $118M+. Combines medication-assisted treatment with digital coaching.
Workit Health is an Ann Arbor, Michigan-based virtual addiction treatment company founded in 2015 that provides evidence-based treatment for opioid use disorder (OUD) and alcohol use disorder (AUD) through a telehealth platform. The company has raised over $118 million and operates in multiple US states, delivering medication-assisted treatment (MAT) including buprenorphine prescribing alongside behavioral health coaching and peer support — all accessible from a member's smartphone.\n\nWorkit Health's model addresses the primary barriers to addiction treatment: stigma, geographic access, and cost. By delivering care via telehealth, the platform reaches patients in rural areas and communities where addiction specialists are scarce. The company accepts Medicaid in multiple states, making treatment accessible to lower-income patients who are disproportionately impacted by the opioid crisis. Clinicians on the platform conduct initial assessments by video, prescribe medications electronically, and monitor patient progress through regular virtual check-ins and app-based engagement tools.\n\nThe platform includes a structured digital program with skills-based modules covering triggers, coping strategies, and recovery maintenance, delivered alongside clinical care. Workit Health competes with Bicycle Health, Ophelia, and Boulder Care in the virtual MAT market. The company has expanded to serve employers and health plans as well as direct consumers, positioning it as both a consumer-facing addiction recovery resource and a value-based care solution for payers managing high-cost substance use disorder populations.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.